Health Catalyst (HCAT) Shares Outstanding (Weighted Average) (2018 - 2026)
Health Catalyst filings provide 9 years of Shares Outstanding (Weighted Average) readings, the most recent being $72.6 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 5.89% to $72.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $72.6 million, a 5.89% increase, with the full-year FY2025 number at $69.9 million, up 16.14% from a year prior.
- Shares Outstanding (Weighted Average) hit $72.6 million in Q1 2026 for Health Catalyst, up from $69.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $72.6 million in Q1 2026 to a low of $53.0 million in Q1 2022.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $58.6 million (2024), compared with a mean of $60.3 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): increased 20.83% in 2022 and later grew 4.46% in 2023.
- Health Catalyst's Shares Outstanding (Weighted Average) stood at $53.7 million in 2022, then grew by 5.02% to $56.4 million in 2023, then grew by 6.68% to $60.2 million in 2024, then rose by 16.14% to $69.9 million in 2025, then grew by 3.86% to $72.6 million in 2026.
- The last three reported values for Shares Outstanding (Weighted Average) were $72.6 million (Q1 2026), $69.9 million (Q4 2025), and $70.4 million (Q3 2025) per Business Quant data.